Health

Element Six and Orbray partner to deliver the world's highest quality wafer-scale single crystal synthetic diamond

GRESHAM, Ore. and TOKYO, June 11, 2024 /PRNewswire/ -- Element Six (E6) and Orbray , both world leaders in high-performing advanced materials, today announced a strategic collaboration to deliver the world's highest quality wafer-scale single crystal ...

2024-06-11 08:00 3310

Full-Life Technologies Disclosed Preclinical Data of its NTSR1-targeting RDC Program FL-091 in an Oral Presentation at the 2024 SNMMI Annual Meeting

SHANGHAI and HEIDELBERG, Germany, June 10, 2024 /PRNewswire/ -- Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, released preclinical data of its NTSR1-targeting RDC program FL-091 in an oral presentation at the 2024 SNMMI (The Society of Nuclear Medicine a...

2024-06-11 08:00 1540

TraceLink Partners with Genpact to Expand Delivery of Digital Supply Chain Innovation for Healthcare and Life Sciences Sectors

TraceLink and Genpact solve supply chain complexities with advanced digital orchestration solutions. BOSTON, June 11, 2024 /PRNewswire/ -- TraceLink, a global leader in digital supply chain solutions, announced it has partnered with Genpact (NYSE: G), a global professional services and solutions...

2024-06-11 02:36 1700

Smartee Successfully Hosts GS Mandibular Repositioning Conference in Spain

MADRID, June 10, 2024 /PRNewswire/ -- The Smartee GS Mandibular Repositioning Technology Conference was successfully held inMadrid, Spain. This gathering provided a unique space for international dental professionals to engage in in-depth dialogue and exchange ideas on Smartee's innovative S8 ort...

2024-06-10 21:19 1295

Octapharma's continuing dedication to improving the lives of people with rare bleeding disorders to be showcased at ISTH 2024

* Octapharma to present new clinical and scientific findings for wilate® and Nuwiq® at the upcoming ISTH 2024 Congress * New data and clinical study developments to be showcased in seven oral presentations, two posters and two Supported Symposia LACHEN, Switzerland, June 10, 2024 /PRNewswire/...

2024-06-10 21:09 2138

Kangpu Biopharmaceuticals to Present Results from Phase 2a of KPG-818 in SLE at EULAR 2024

HEFEI, China, June 10, 2024 /PRNewswire/ -- Kangpu Biopharmaceuticals today announced that a poster tour presentation highlighting the Phase 2a clinical data of KPG-818 in patients with Systemic Lupus Erythematosus (SLE) will be presented at the upcoming Annual European Congress of Rheumatology E...

2024-06-10 20:00 1771

FDA Grants Fast Track Designation to GCBP and Novel Pharma's GC1130A

* FDA's Fast Track designation speeds up the development of new biologic drugs for rare diseases YONGIN, South Korea, June 10, 2024 /PRNewswire/ -- GC Biopharma (006280. KS) and Novel Pharma have announced that the U.S. FDA has granted Fast Track Designation for their jointly developed MPSIIIA ...

2024-06-10 16:18 2066

India Breakthrough: Bio Regenerative Precision Medicine Seminar Held in Hyderabad

HYDERABAD, India, June 10, 2024 /PRNewswire/ -- The Bio Regenerative Precision Medicine Seminar, held fromMay 18-20, 2024, at Le Méridien in Hyderabad, was a watershed moment inIndia's cell treatment journey. Prof. Dr Mike Chan, Chairman and Founder of European Wellness Biomedical Group (EWBG)...

2024-06-10 15:40 1893

J INTS BIO, ASCO 2024 - JIN-A02 showed tumor reductions including brain metastasis in the ongoing first-in-human, dose-finding Phase 1 clinical study

SEOUL, South Korea, June 10, 2024 /PRNewswire/ -- J INTS BIO provided an update of its ongoing Phase 1 clinical study of JIN-A02, a 4th generation EGFR-TKI for NSCLC treatment, during the 3rd of June poster session of the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting held at Mc...

2024-06-10 13:56 1654

DeepQure receives IDE Approval from FDA for its EFS study to treat Resistant Hypertension with its Extravascular Renal Denervation Technology (HyperQure™)

SEOUL, South Korea, June 10, 2024 /PRNewswire/ -- DeepQure, a Seoul based medical device company with a novel, extravascular (laparoscopic approach) solution for renal denervation (RDN), today announced initiation of its Early Feasibility Study (EFS) for the HyperQure™ system following FDA IDE ap...

2024-06-10 13:14 1616

Dontia Alliance introduced its first Advanced Implant Strategies Centre of Excellence in Malaysia and four (4) other centres are in the pipeline

* The first AIS Centre was launched in Penang, Malaysia on 8 June 2024 *  Four (4) more AIS Centres are slated to be launched in Singapore, Hong Kong (SAR), Vietnam and the Philippines in the next two years SINGAPORE, June 10, 2024 /PRNewswire/ -- Dontia Alliance Pte. Ltd. ("DA") introduced its...

2024-06-10 10:00 2777

United Imaging Prepares to Ship its 30,000th Unit Globally, a uMI Panorama GS, from Houston for U.S. Installation

The uMI Panorama GS is among the all-digital Molecular Imaging systems United Imaging is featuring at SNMMI in Toronto SHANGHAI, June 8, 2024 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, is on the brink of a significant milestone as it a...

2024-06-08 21:00 4014

ILJIN SNT Co., Ltd. Announces Its Intention to Vote Against Aurinia Pharmaceuticals's Revised Equity Incentive Plan Proposal

SEOUL, South Korea, June 7, 2024 /PRNewswire/ -- Dear Fellow Shareholders, ILJIN SNT Co., Ltd. ("ILJIN") is a long-standing investor of Aurinia Pharmaceuticals Inc. ("Aurinia" or the "Company"), and, together with its affiliates, currently holds more than 5% of Aurinia's common stock. As one of...

2024-06-07 23:49 5699

deCODE genetics: The rate, nature and transmission of mitochondrial DNA mutations in humans

A new study from deCODE genetics uses pedigrees and sequence data from 64,806 Icelanders to shed light on the rate and nature of mutations in mitochondrial DNA (mtDNA) and the peculiar dynamics of its maternal transmission REYKJAVIK, Iceland, June 7, 2024 /PRNewswire/ -- In a paper published toda...

2024-06-07 23:00 2730

Tsingke Concludes a Successful Showcase at TIDES USA 2024: Advancing Biotechnology Frontiers

BEIJING and PARIS, June 7, 2024 /PRNewswire/ -- Tsingke successfully wrapped up its debut at TIDES USA 2024, the premier event for oligonucleotides, peptides, mRNA, and genome editing. Held fromMay 14-17 at the Hynes Convention Center in Boston, the conference brought ...

2024-06-07 22:09 4206

Amorepacific Hosts NBRI Symposium

Announces Results of Skin Aging Research Conducted in collaboration with The Johns Hopkins University School of Medicine SEOUL, South Korea, June 7, 2024 /PRNewswire/ -- Amorepacific hosted the "New Beauty Research Initiative (NBRI) Symposium" at its R&I Center in Yongin, Korea, onWednesday, Jun...

2024-06-07 21:00 3951

THRIVING BEYOND CANCER: Pantai Hospital Kuala Lumpur's Heartfelt Month of Celebration and Support to Cancer Survivors with Special June Activities

KUALA LUMPUR, Malaysia, June 7, 2024 /PRNewswire/ -- Pantai Hospital Kuala Lumpur (PHKL), a beacon of medical excellence and compassionate patient care, proudly announces a series of events in celebration ofCancer Survivor Month. These activities underscore PHKL's unwavering commitment to support...

2024-06-07 20:50 4604

IONETIX Produces First Batch of Actinium-225

LANSING, Mich., June 7, 2024 /PRNewswire/ -- IONETIX, a leading cyclotron technology innovator, isotope producer, and radiopharmaceutical manufacturer, announced today the successful production of Actinium-225 ("Ac-225") at its isotope manufacturing facility located inLansing, Michigan. This fir...

2024-06-07 20:27 1833

Brii Bio Presents New Data from Its Ongoing Phase 2 Chronic Hepatitis B Trials at EASL™ Congress 2024

New translational data demonstrate that BRII-179-induced immune responses are associated with high HBsAg reduction in a subset of participants with chronic HBV infection BRII-179 as add-on therapy induces functional antibody responses and contributes toimproved sustained HBsAg loss in PEG-IFNa-t...

2024-06-07 19:00 2414

Clinical Data of First-in-class HBV-specificTCR T Cell Therapy (SCG101) Presented at ESAL Congress Showing Improved Overall Survival in HBV-related Hepatocellular Carcinoma

SINGAPORE, June 7, 2024 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, announced that clinical data from its first-in-class autologous hepatitis B virus (HBV)-specific...

2024-06-07 16:51 2433
1 ... 71727374757677 ... 858